Kexxtone 32.4 g - Continuous-release intraruminal device
- Monensin
Product identification
- Monensin
-
Cattle (cow)
-
Cattle (heifer)
-
Intraruminal use
Product details
-
Monensin35160.00milligram(s)1.00Bag
-
Continuous-release intraruminal device
-
Intraruminal use
-
Cattle (cow)
-
Cattle (heifer)
-
- QA16QA06
-
Veterinary medicinal product subject to veterinary prescription
-
Suspended
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Additional information
-
Marketing Authorisation
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
- Elanco GmbH
- Elanco France S.A.S.
- European Commission
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
Kexxtone_Art 130-4_Annexes I-II_LT.pdf
Kexxtone_Art 130-4_Annexes I-II_LV.pdf
Kexxtone_Art 130-4_Annexes I-II_MT.pdf
Kexxtone_Art 130-4_Annexes I-II_NL.pdf
Kexxtone_Art 130-4_Annexes I-II_NO.pdf
Kexxtone_Art 130-4_Annexes I-II_PL.pdf
Kexxtone_Art 130-4_Annexes I-II_PT.pdf
Kexxtone_Art 130-4_Annexes I-II_RO.pdf
Kexxtone_Art 130-4_Annexes I-II_SK.pdf
Kexxtone_Art 130-4_Annexes I-II_SL.pdf
Kexxtone_Art 130-4_Annexes I-II_SV.pdf
Kexxtone_Art 130-4_Annexes I-II_BG.pdf
Kexxtone_Art 130-4_Annexes I-II_CS.pdf
Kexxtone_Art 130-4_Annexes I-II_DA.pdf
Kexxtone_Art 130-4_Annexes I-II_DE.pdf
Kexxtone_Art 130-4_Annexes I-II_EL.pdf
Kexxtone_Art 130-4_Annexes I-II_EN.pdf
Kexxtone_Art 130-4_Annexes I-II_ES.pdf
Kexxtone_Art 130-4_Annexes I-II_ET.pdf
Kexxtone_Art 130-4_Annexes I-II_FI.pdf
Kexxtone_Art 130-4_Annexes I-II_FR.pdf
Kexxtone_Art 130-4_Annexes I-II_GA.pdf
Kexxtone_Art 130-4_Annexes I-II_HR.pdf
Kexxtone_Art 130-4_Annexes I-II_HU.pdf
Kexxtone_Art 130-4_Annexes I-II_IS.pdf
Kexxtone_Art 130-4_Annexes I-II_IT.pdf
ema-puar-kexxtone-v-2235-par-en.pdf